A B C D E F G H I J K L M N O P Q R S T U V W X Y Z # |
2,3-Dinor 11B-Prostaglandin F2A, Urine, 24-hour
MessageSendout, Mayo test code: 23BPT
Test Code
LAB5210234
Alias/See Also
11 Beta-Prostaglandin F2 Alpha
11BPG
2,3 11 Beta-Prostaglandin F2 Alpha
23BPG
BPG2
Mastocytosis
Prostaglandin
23BPT
23
BPT23
11BPG
2,3 11 Beta-Prostaglandin F2 Alpha
23BPG
BPG2
Mastocytosis
Prostaglandin
23BPT
23
BPT23
CPT Codes
84150, 82570
Preferred Specimen
5 mL urine collected from a 24-hour urine container.
Patient Preparation
Patients taking aspirin or nonsteroidal anti-inflammatory drugs (NSAID) may have decreased concentrations of prostaglandin F2 alpha. If possible, discontinue for 2 weeks or 72 hours, respectively, prior to collecting a specimen.
Minimum Volume
4 mL
Other Acceptable Specimens
URINE PRESERVATIVE COLLECTION OPTIONS
Note: The addition of preservative or application of temperature controls must occur within 4 hours of completion of the collection.
Ambient | No |
Refrigerate | Preferred |
Frozen | OK |
50% Acetic Acid | OK |
Boric Acid | OK |
Diazolidinyl Urea | No |
6M Hydrochloric Acid | No |
6M Nitric Acid | No |
Sodium Carbonate | OK |
Thymol | No |
Toluene | No |
Instructions
1. Collect urine for 24 hours.
2. No preservative preferred.
2. No preservative preferred.
Transport Container
Plastic, 5-mL tube
Transport Temperature
Refrigerated
Specimen Stability
Refrigerated (preferred): 14 days
Frozen: 30 days
Ambient: 8 hours
Frozen: 30 days
Ambient: 8 hours
Methodology
T23BP: Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS)
CRT24: Enzymatic Colorimetric Assay
FDA Status
Approved
Setup Schedule
Tuesday, Thursday
Report Available
3-8 days
Limitations
Elevated levels of 2,3-dinor-11beta-prostaglandin F2 alpha (2,3 BPG) in urine are not specific for systemic mast cell disease and may be found in patients with angioedema, diffuse urticaria, or myeloproliferative diseases in the absence of diffuse mast cell proliferation.
Systemic mast cell disease is a heterogeneous disease, and some patients may not have elevated 2,3 BPG in urine.
Systemic mast cell disease is a heterogeneous disease, and some patients may not have elevated 2,3 BPG in urine.
Reference Range
Included with report
Clinical Significance
Screening for mast cell activation disorders including systemic mastocytosis using 24-hour urine specimens
Performing Laboratory
Mayo Clinic Laboratories, Rochester, Minnesota
Additional Information
2,3-Dinor 11 Beta-Prostaglandin F2 Alpha, 24 Hour, Urine